Burcon NutraScience heads into its next earnings report with a much higher revenue forecast. But after four straight quarters of larger-than-expected losses, investors will also be watching its EPS outlook closely.
Burcon NutraScience Corporation (TSX: BU, BU.TO) is scheduled to report results after the market closes on November 11, 2026. The report covers the quarter ended September 30. One analyst expects a loss of C$0.04 per share and revenue of C$2.60 million. The EPS estimate is less negative than the year-ago figure of C$0.28 per share, while the revenue forecast implies 627.9% growth. That points to strong expected sales growth, but the estimate is based on just one analyst. Burcon has also missed EPS estimates in each of its last four reported quarters.
Recent earnings trend
Burcon NutraScience Corporation
BU.TO
BU.TO
Burcon NutraScience Corporation
WealthAwesomeMarket cap
$12.06M
52W high
$2.50
52W low
$0.90
1W change
+5.21%
Beta
2.93
Analyst Price Targets
Based on analyst covering BU · as of Sep 17, 2026
Wall Street analysts forecast BU stock price to rise 83.2% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.85
+83.2% Upside
Current Price
C$1.01
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on BU's historical volatility
30-Day Vol
102.7%
Annualized
90-Day Vol
80.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.79
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.90 | C$0.63 – C$1.28 |
| 60 trading days | C$0.84 | C$0.51 – C$1.39 |
| 90 trading days | C$0.79 | C$0.43 – C$1.47 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-09-30 | 2026-11-11 | — | -0.1700 | — |
| 2026-06-30 | 2026-08-12 | -0.3000 | -0.0700 | -328.6% |
| 2026-03-31 | 2026-06-24 | -0.2900 | -0.1000 | -190.0% |
| 2025-12-31 | 2026-02-11 | -0.2800 | -0.0400 | -600.0% |
| 2025-09-30 | 2025-11-12 | -0.2800 | -0.0500 | -460.0% |
| 2025-06-30 | 2025-08-13 | -0.2739 | -0.0700 | -291.3% |
Investor takeaway: This report will show whether Burcon can turn its commercial ramp into meaningful sales growth while managing losses and funding production plans. The one-analyst consensus points to higher revenue and a smaller loss, but investors should weigh it against four recent EPS misses, the company’s stated production-ramp challenges and its financing needs. Visit the Burcon stock page for more company and share information.
C$2.60 million
That’s the one-analyst revenue estimate for the quarter ended September 30, implying 627.9% growth from a year earlier. It’s a benchmark, not a promise. The results will show whether Burcon’s commercial ramp is generating sales at that pace.
Bull case
The C$2.60 million revenue estimate points to potential year-over-year growth of 627.9%. Burcon reported C$1.3 million in revenue for its fiscal first quarter, ended June 30. That was up 273% from a year earlier and 54% from the previous quarter, giving investors a recent measure of its commercial momentum.
The EPS estimate has also improved, moving from a loss of C$0.05 to C$0.04 per share over the past 30 days. One analyst revised the estimate upward, and none revised it downward. If sales continue to grow and the company executes better, investors may see progress toward Burcon’s revenue and cash-flow goals.
Bear case
Burcon has missed EPS estimates in each of its last four comparable quarters, reporting losses of C$0.30, C$0.29, C$0.28 and C$0.28 per share. In its latest reported quarter, it used C$2.4 million in operating cash and ended the quarter with C$0.9 million in cash.
The company has said delays in ramping up production and spending to improve manufacturing reliability led it to lower its near-term outlook. Higher revenue alone won’t answer questions about margins, cash use or how quickly production can ramp up.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
